JSNM/JSNMT2018

Presentation information

Print

[Joint]

Joint Program » Luncheon Seminar

Luncheon Seminar 3

Targeted Alpha Therapy for mCRPC: Learnings in 2 years after the launch of Ra-223 in Japan and future challenges

Thu. Nov 15, 2018 11:45 AM - 12:45 PM Room4 (Conference Building B 2F B1)

Chair:Mitsuru Koizumi (Department of Nuclear Medicine, Cancer Institute Hospital)

Sponsored by Bayer Yakuhin, Ltd.

[LS3-1] Current status and issues of Ra-223 dichloride therapy

Koichiro Abe (Professor, Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women's Medical University)